Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Strata Critical Medical (SRTA) EBIAT (2019 - 2025)

Strata Critical Medical (SRTA) has disclosed EBIAT for 7 consecutive years, with -$8.8 million as the latest value for Q4 2025.

  • Quarterly EBIAT fell 18.88% to -$8.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $41.3 million through Dec 2025, up 265.76% year-over-year, with the annual reading at $41.3 million for FY2025, 355.84% up from the prior year.
  • EBIAT for Q4 2025 was -$8.8 million at Strata Critical Medical, down from $57.4 million in the prior quarter.
  • The five-year high for EBIAT was $57.4 million in Q3 2025, with the low at -$33.9 million in Q4 2023.
  • Average EBIAT over 5 years is -$5.8 million, with a median of -$8.1 million recorded in 2024.
  • The sharpest move saw EBIAT crashed 9069.79% in 2021, then surged 3038.38% in 2025.
  • Over 5 years, EBIAT stood at $772000.0 in 2021, then plummeted by 3631.09% to -$27.3 million in 2022, then dropped by 24.51% to -$33.9 million in 2023, then skyrocketed by 78.11% to -$7.4 million in 2024, then fell by 18.88% to -$8.8 million in 2025.
  • According to Business Quant data, EBIAT over the past three periods came in at -$8.8 million, $57.4 million, and -$3.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.